跳至主導覽
跳至搜尋
跳過主要內容
國立中央大學 首頁
說明與常見問題
English
中文
首頁
人才檔案
研究單位
研究計畫
研究成果
資料集
榮譽/獲獎
學術活動
新聞/媒體
影響
按專業知識、姓名或所屬機構搜尋
合併前二期貝氏調整型臨床試驗設計(1/2)
Chen, Yuh-Ing
(PI)
統計研究所
概覽
指紋
指紋
探索此專案觸及的研究主題。這些標籤是根據基礎獎勵/補助款而產生。共同形成了獨特的指紋。
排序方式
重量
按字母排序
Keyphrases
Dose-limiting Toxicity
100%
Adaptive Bayesian Design
100%
Clinical Trials
100%
Posterior Probability
60%
Phase II Trial
60%
Short-term Efficacy
40%
Phase III Clinical Trial
40%
Maximum Tolerated Dose
40%
Toxicity Response
40%
Adaptive Phase
40%
Short-term Response
20%
Number of Subjects
20%
Batch Experiments
20%
Adverse Effects
20%
First Year
20%
Drug Development
20%
Phase I Trial
20%
Toxicity Effects
20%
Adaptive Clinical Trials
20%
Late Toxicity
20%
Bayesian Hypothesis Testing
20%
Binary Response
20%
Pharmacology, Toxicology and Pharmaceutical Science
Clinical Trial
100%
Phase II Trials
50%
Maximum Tolerated Dose
50%
Phase I Trials
25%
Dose Toxicity
25%
Drug Development
25%
Adverse Event
25%
Adaptive Clinical Trial
25%
Biochemistry, Genetics and Molecular Biology
Clinical Trial
100%
Maximum Tolerated Dose
50%
Phase II Trials
50%
Phase I Trials
25%
Adaptive Clinical Trial
25%